Literature DB >> 24553095

Bleeding complications in patients undergoing percutaneous coronary interventions: current status and perspective.

Gjin Ndrepepa1, Adnan Kastrati.   

Abstract

Bleeding complications are among the most common complications of percutaneous coronary intervention (PCI) procedures. A multitude of studies carried out over the last decade have confirmed that bleeding complications after PCI have a negative impact on patients' outcome (dissatisfaction, morbidity, and mortality) and hospital indices (length of stay and costs). Apart from better recognition and classification of bleeding, recent research has helped to device several risk stratification tools that have markedly improved prediction of peri-PCI bleeding. Moreover, parallel with the recognition of the deleterious effects of peri-PCI bleeding, several strategies (pre-PCI risk stratification for bleeding, the use of bivalirudin as an antithrombotic/anticoagulant strategy, the radial artery route for vascular access and vascular closure devices) that aim to reduce peri-PCI bleeding were developed and used. Their application has markedly reduced the incidence of bleeding and improved the clinical outcome. In this review, we focus primarily on the bleeding complications occurring during PCI procedures. Specifically, we summarize recent research on the need for a consensus in bleeding definition, incidence of bleeding events, and their impact on outcome, factors associated with increased risk and risk stratification for bleeding, putative mechanisms through which bleeding impact on outcome, and bleeding-avoidance strategies to be used in the setting of PCI procedures.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24553095     DOI: 10.1097/MCA.0000000000000096

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  3 in total

1.  High-loading Gα13-binding EXE peptide nanoparticles prevent thrombosis and protect mice from cardiac ischemia/reperfusion injury.

Authors:  Aiming Pang; Ni Cheng; Yujie Cui; Yanyan Bai; Zhigang Hong; M Keegan Delaney; Yaping Zhang; Claire Chang; Can Wang; Chang Liu; Paola Leon Plata; Alexander Zakharov; Kasim Kabirov; Jalees Rehman; Randal A Skidgel; Asrar B Malik; Ying Liu; Aleksander Lyubimov; Minyi Gu; Xiaoping Du
Journal:  Sci Transl Med       Date:  2020-07-15       Impact factor: 17.956

2.  Current Antithrombotic Therapy in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Interventions.

Authors:  Gabriele Pesarini; Sara Ariotti; Flavio Ribichini
Journal:  Interv Cardiol       Date:  2014-04

3.  Impact of diabetes on bleeding events in ST-elevation myocardial infarction patients after urgent percutaneous coronary intervention: A retrospective cohort study.

Authors:  Huairong Zhang; Xiaowen Hu; Qian Wu; Bingyin Shi
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.